ARCHIVES

DCPC Advisors Upset At NCAB Over Why Decision, But Move On

This article is from The Cancer Letter archive.

Vol. 17 No. 06 | February 8, 1991

Download PDF Visit The Full Archive

Related Articles

The Tivozanib Timeline

May 10, 2013

GA101 Associated with Better PFS In Phase III Trial Versus Rituximab in CLL

July 26, 2013

ACR Defends Mammographic Exams For Women 35-40,Says Carcinogenic Threat Is “Small”

July 30, 1976

Members of Congress say that won’t work.

September 30, 2005

NCI Appropriations Still Hung Up

September 30, 1977

NIH Considering Intramural NRSA, NCI Advisors Not Enthusiastic

February 17, 1984